Assessing protection against OP pesticides and nerve agents provided by wild-type HuPON1 purified from Trichoplusia ni larvae or induced via adenoviral infection

Chemico-Biological Interactions

Volumn 203, Issue 1, 2013, Pages 177-180

  Hodgins, Sean M ^a   Kasten, Shane A ^a   Harrison, Joshua ^a   Otto, Tamara C ^a   Oliver, Zeke P ^a   Rezk, Peter ^a   Reeves, Tony E ^a   Chilukuri, Nageswararao ^a   Cerasoli, Douglas M ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Catalytic bioscavenger; In vivo efficacy; Nerve agent; Organophosphorus; Paraoxonase 1

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; CHLORPYRIFOS OXON; CYCLOSARIN; DIAZOXON; INSECT LARVA PRODUCED RECOMBINANT HUMAN PARAOXONASE 1; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; NERVE GAS; ORGANOPHOSPHATE PESTICIDE; SARIN; SOMAN; TABUN; UNCLASSIFIED DRUG;

ADENOVIRUS INFECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; IN VIVO STUDY; INTOXICATION; MALE; MOTH; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TRICHOPLUSIA NI; WILD TYPE;

ANIMALS; ANTIDOTES; ARYLDIALKYLPHOSPHATASE; CHEMICAL WARFARE AGENTS; CHLORPYRIFOS; GUINEA PIGS; HUMANS; MALE; MICE; MOTHS; ORGANOPHOSPHATES; ORGANOPHOSPHORUS COMPOUNDS; PESTICIDES; RECOMBINANT PROTEINS; SARIN; SOMAN;

ADENOVIRIDAE; ANIMALIA; CAVIA; MUS; TRICHOPLUSIA NI;

EID: 84875811149     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2012.10.015     Document Type: Conference Paper

References (24)

1. M. Ben-David, M. Elias, J.J. Filippi, E. Dunach, I. Silman, J.L. Sussman, and D.S. Tawfik Catalytic versatility and backups in enzyme active sites: the case of serum paraoxonase 1 J. Mol. Biol. 418 2012 181 196
2. B. Mackness, P.N. Durrington, and M.I. Mackness Human serum paraoxonase Gen. Pharmacol. 31 1998 329 336
3. S. Billecke, D. Draganov, R. Counsell, P. Stetson, C. Watson, C. Hsu, and B.N. La Du Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters Drug. Metab. Dispos. 28 2000 1335
4. L. Gaidukov, M. Rosenblat, M. Aviram, and D.S. Tawfik The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, stimulation of lipo-lactonase, and macrophage cholesterol efflux 2006 J. Lipid Res.
5. L. Rodrigo, B. Mackness, P.N. Durrington, A. Hernandez, and M.I. Mackness Hydrolysis of platelet-activating factor by human serum paraoxonase Biochem. J. 354 2001 1
6. D.T. Yeung, D. Josse, J.D. Nicholson, A. Khanal, C.W. McAndrew, B.J. Bahnson, D.E. Lenz, and D.M. Cerasoli Structure/function analyses of human serum paraoxonase (HuPON1) mutants designed from a DFPase-like homology model Biochim. Biophys. Acta 1702 2004 67
7. D.T. Yeung, J.R. Smith, R.E. Sweeney, D.E. Lenz, and D.M. Cerasoli Direct detection of stereospecific soman hydrolysis by wild-type human serum paraoxonase Febs J. 274 2007 1183 1191
8. R. Humbert, D.A. Adler, C.M. Disteche, C. Hassett, C.J. Omiecinski, and C.E. Furlong The molecular basis of the human serum paraoxonase activity polymorphism Nat. Genet. 3 1993 73 76
9. H.G. Davies, R.J. Richter, M. Keifer, C.A. Broomfield, J. Sowalla, and C.E. Furlong The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin Nat. Genet. 14 1996 334
10. D.T. Yeung, D.E. Lenz, and D.M. Cerasoli Analysis of active-site amino-acid residues of human serum paraoxonase using competitive substrates FEBS J. 272 2005 2225
11. M. Sarkar, C.K. Harsch, G.T. Matic, K. Hoffman, J.R. Norris 3rd, T.C. Otto, D.E. Lenz, D.M. Cerasoli, and T.J. Magliery Solubilization and humanization of paraoxonase-1 J. Lipids 2012 2012 610937
12. M. Goldsmith, Y. Ashani, Y. Simo, M. Ben-David, H. Leader, I. Silman, J.L. Sussman, and D.S. Tawfik Evolved stereoselective hydrolases for broad-spectrum G-type nerve agent detoxification Chem. Biol. 19 2012 456 466
13. R.C. Stevens, S.M. Suzuki, T.B. Cole, S.S. Park, R.J. Richter, and C.E. Furlong Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning Proc. Natl. Acad. Sci. USA 105 2008 12780 12784
14. W.F. Li, L.G. Costa, R.J. Richter, T. Hagen, D.M. Shih, A. Tward, A.J. Lusis, and C.E. Furlong Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds Pharmacogenetics 10 2000 767
15. E.G. Duysen, K. Parikh, V. Aleti, V. Manne, O. Lockridge, and N. Chilukuri Adenovirus-mediated human paraoxonase1 gene transfer to provide protection against the toxicity of the organophosphorus pesticide toxicant diazoxon Gene Ther. 18 2011 250 257
16. D.E. Lenz, C.A. Broomfield, D.T. Yeung, P. Masson, D.M. Maxwell, and D.M. Cerasoli Nerve agent bioscavengers: progress in development of a new mode of protection against organophosphorus exposure J.A. Romano, B. Lukey, H. Salem, Chemical Warfare Agents: Toxicity at Low Levels second ed. 2007 CRC Press Boca Raton 175 202
17. P. Masson, F. Nachon, C.A. Broomfield, D.E. Lenz, L. Verdier, L.M. Schopfer, and O. Lockridge A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters Chem. Biol. Interact. 175 2008 273 280
18. R.D. Gupta, M. Goldsmith, Y. Ashani, Y. Simo, G. Mullokandov, H. Bar, M. Ben-David, H. Leader, R. Margalit, I. Silman, J.L. Sussman, and D.S. Tawfik Directed evolution of hydrolases for prevention of G-type nerve agent intoxication Nat. Chem. Biol. 7 2011 120 125
19. M. Valiyaveettil, Y. Alamneh, L. Biggemann, I. Soojhawon, H.A. Farag, P. Agrawal, B.P. Doctor, and M.P. Nambiar In vitro efficacy of paraoxonase 1 from multiple sources against various organophosphates Toxicol. In Vitro 25 2011 905 913
20. M. Valiyaveettil, Y. Alamneh, P. Rezk, M.W. Perkins, A.M. Sciuto, B.P. Doctor, and M.P. Nambiar Recombinant paraoxonase 1 protects against sarin and soman toxicity following microinstillation inhalation exposure in guinea pigs Toxicol. Lett. 202 2011 203 208
21. M. Valiyaveettil, Y. Alamneh, P. Rezk, L. Biggemann, M.W. Perkins, A.M. Sciuto, B.P. Doctor, and M.P. Nambiar Protective efficacy of catalytic bioscavenger, paraoxonase 1 against sarin and soman exposure in guinea pigs Biochem. Pharmacol. 81 2011 800 809
22. M. Valiyaveettil, Y. Alamneh, L. Biggemann, I. Soojhawon, B.P. Doctor, and M.P. Nambiar Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1 Biochem. Biophys. Res. Commun. 403 2010 97 102
23. T.C. Otto, S.A. Kasten, E. Kovaleva, Z. Liu, G. Buchman, M. Tolosa, D. Davis, J.R. Smith, R. Balcerzak, D.E. Lenz, and D.M. Cerasoli Purification and characterization of functional human paraoxonase-1 expressed in Trichoplusia ni larvae Chem. Biol. Interact. 187 2010 388 392
24. T.C. Otto, C.K. Harsch, D.T. Yeung, T.J. Magliery, D.M. Cerasoli, and D.E. Lenz Dramatic differences in organophosphorus hydrolase activity between human and chimeric recombinant mammalian paraoxonase-1 enzymes Biochemistry 48 2009 10416 10422